These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 5924792)
21. Mechanism and pharmacology of shock due to rattlesnake venom in sheep. Halmagyi DF; Starzecki B; Horner GJ J Appl Physiol; 1965 Jul; 20(4):709-18. PubMed ID: 4284507 [No Abstract] [Full Text] [Related]
22. The dilemma of vasopressors and vasodilators in the therapy of shock. Shoemaker WC; Brown RS Surg Gynecol Obstet; 1971 Jan; 132(1):51-7. PubMed ID: 5538813 [No Abstract] [Full Text] [Related]
23. EFFECTS OF HYDRALAZINE AND HIGH MOLECULAR WEIGHT DEXTRAN UPON THE CIRCULATORY RESPONSES TO SEVERE THERMAL BURNS. MICHIE DD; GOLDSMITH RS; MASON AD Circ Res; 1963 Nov; 13():468-73. PubMed ID: 14077309 [No Abstract] [Full Text] [Related]
25. [Effect of dopamine on cardiac performance in an early postburn period]. Nishina M Nihon Geka Gakkai Zasshi; 1993 Jan; 94(1):13-20. PubMed ID: 8437549 [TBL] [Abstract][Full Text] [Related]
26. The effect of phenoxybenzamine on muscle blood-flow and lactic acidosis in haemorrhagic shock in dogs. Makin GS; Walder DN Br J Surg; 1970 May; 57(5):389. PubMed ID: 5427910 [No Abstract] [Full Text] [Related]
32. Effects of ganglionic blockade upon the renal and cardiovascular dysfunction induced by thermal injury. Turner R; Carvajal HF; Traber DL Circ Shock; 1977; 4(2):103-13. PubMed ID: 923012 [TBL] [Abstract][Full Text] [Related]
33. Indications for adrenergic stimulators in shock. Mills LC; Moyer JH Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):385-95. PubMed ID: 5566718 [No Abstract] [Full Text] [Related]
34. The effect of various treatments on renal function during endotoxin shock. An experimental study in dogs. Knuth OE; Wagenknecht LV; Madsen PO Invest Urol; 1972 Jan; 9(4):304-9. PubMed ID: 5058769 [No Abstract] [Full Text] [Related]
35. Reduced resuscitation fluid volume for second-degree experimental burns with delayed initiation of vitamin C therapy (beginning 6 h after injury). Sakurai M; Tanaka H; Matsuda T; Goya T; Shimazaki S; Matsuda H J Surg Res; 1997 Nov; 73(1):24-7. PubMed ID: 9441788 [TBL] [Abstract][Full Text] [Related]
36. DEXTRAN IN THE TREATMENT OF EXPERIMENTAL BURNS. FOGELMAN MJ; WILSON BJ J Trauma; 1963 Nov; 3():583-9. PubMed ID: 14078084 [No Abstract] [Full Text] [Related]
37. The pharmacologic approach to the treatment of shock. I. Defining traumatic, septic, and cardiogenic shock. Lillehei RC; Dietzman RH; Motsay GJ; Schultz LS; Romero LH; Beckman CB Geriatrics; 1972 Jul; 27(7):73-83. PubMed ID: 5039885 [No Abstract] [Full Text] [Related]
38. The effects of nicotinic acid upon postburn plasma volume loss. Hilton JG; Wells CH Surg Gynecol Obstet; 1975 Dec; 141(6):882-4. PubMed ID: 1188565 [TBL] [Abstract][Full Text] [Related]
39. Dopamine in the treatment of shock. Shanbour LL Adv Exp Med Biol; 1971 Oct; 23(0):245-52. PubMed ID: 4950808 [No Abstract] [Full Text] [Related]
40. Blood volume, hemodynamic, and metabolic changes in hemorrhagic shock in normal and splenectomized dogs. Chien S; Dellenback RJ; Usami S; Burton DA; Gustavson PF; Magazinovic V Am J Physiol; 1973 Oct; 225(4):866-79. PubMed ID: 4743378 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]